Close

TNFSF14

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF14, which is a member of the tumor necrosis factor receptor superfamily, and which is also known as a herpesvirus entry mediator (HVEM). This protein may function as a costimulatory factor for the activation of lymphoid cells and as a deterrent to infection by herpesvirus. This protein has been shown to stimulate the proliferation of T cells, and trigger apoptosis of various tumor cells. This protein is also reported to prevent tumor necrosis factor alpha mediated apoptosis in primary hepatocyte. Two alternatively spliced transcript variant encoding distinct isoforms have been reported.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-CQ3397 Anti-TNFSF14 (CBXC-0766) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXC-0766 Human scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ6821 Anti-TNFSF14 (CBXC-0766) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXC-0766 Human scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3250 Anti-TNFSF14 (CBFYC-3189) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse, Human CBFYC-3189 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6503 Anti-TNFSF14 (CBFYC-3189) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse, Human CBFYC-3189 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2103 Anti-TNFSF14 (CBWJN-1698) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBWJN-1698 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ4395 Anti-TNFSF14 (CBWJN-1698) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBWJN-1698 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ161 Anti-TNFSF14 (XHM537) h(41BB-CD3ζ) CAR, pCDCAR1 Human XHM537 Human scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ283 Anti-TNFSF14 (XHM538) h(41BB-CD3ζ) CAR, pCDCAR1 Human XHM538 Human scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ661 Anti-TNFSF14 (XHM537) h(CD28-CD3ζ) CAR, pCDCAR1 Human XHM537 Human scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ783 Anti-TNFSF14 (XHM538) h(CD28-CD3ζ) CAR, pCDCAR1 Human XHM538 Human scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1222-ZP1218 TNFSF14 (LTBR Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 Human TNFSF14-CD28-CD6ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1222-ZP1219 TNFSF14 (TNFRSF14 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 Human TNFSF14-CD28-CD6ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1222-ZP1220 TNFSF14 (TNFRSF6B Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 Human TNFSF14-CD28-CD6ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1222-ZP2618 TNFSF14 (LTBR Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 Human TNFSF14-41BB-CD6ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1222-ZP2619 TNFSF14 (TNFRSF14 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 Human TNFSF14-41BB-CD6ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1222-ZP2620 TNFSF14 (TNFRSF6B Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 Human TNFSF14-41BB-CD6ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.